The route to success starts with AI-driven scouting

Laden...

4 maanden geleden

Html
Tekst

This week's Fierce Biotech is brought to you by Lonza.
Trouble viewing? Click here.

Intelligent Route Scouting that Helps Deliver Efficiency and Scalability

The complex nature of small molecule development can present challenges for many pharmaceutical drug developers, specifically smaller operations.

Lonza's AI-Enabled Route Scouting Service reduces project risks by providing you with the insight and commercial intelligence to make decisions now that make the journey from compound to clinical trials more successful and cost-effective.

Learn more

Explore a suite of resources to understand how to maximize your opportunities with Route Scouting.

Join industry experts as they share how Lonza's custom AI-enabled Route Scouting Service helps partners mitigate API complexity and accelerate IND readiness.

This white paper outlines Lonza's advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.

Download the white paper →

Dr. Simon Wagschal, Associate Director, Small Molecules R&D at Lonza, describes how increasingly complex molecules require a more advanced approach to Route Scouting.

Watch the video →

Ready to overcome the complexities of pharmaceutical manufacturing by utilizing Lonza's subject-matter expertise combined with the power of AI?

Contact Lonza today

If you no longer wish to receive communications from Lonza, please opt out here.

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.

You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017

Deel deze op

Laden...

Andere nieuwsbrieven van Fiercebiotech.com

| 11.23.24 | House passes sweeping nonprofits bill; Trump taps Dr. Oz to run CMS Fiercebiotech.com
18 uren geleden
| 11.22.24 | Halozyme ends $2B pursuit of 'unwilling' Evotec; Lexicon cuts 60% of workforce Fiercebiotech.com
Gisteren om 20:32
| 11.22.24 | Rett patient dies in Neurogene trial; AZ scraps opioid disorder drug over antifungal interaction Fiercebiotech.com
Gisteren om 17:35

Meer nieuwsbrieven van Fiercebiotech.com

Laden...

The route to success starts with AI-driven scouting

Deel deze op

Andere nieuwsbrieven van Fiercebiotech.com

Gerelateerde nieuwsbrieven